๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB ยท Real-Time Price ยท USD
5.82
-0.10 (-1.69%)
At close: Nov 18, 2026, 4:00 PM EST
5.70
-0.12 (-2.06%)
After-hours: Nov 18, 2026, 7:56 PM EST

AgomAb Therapeutics NV Earnings Call Transcripts

Fiscal Year 2026

  • Study result

    In the 49-patient STENOVA open-label extension, ontunisertib maintained favorable safety and gut-restricted PK through up to 60 weeks. Exploratory findings included a 3% event rate and 97% clinical remission at week 48, with efficacy interpretation limited by the uncontrolled design.